219 related articles for article (PubMed ID: 12231370)
61. Effects of immunosuppression with tacrolimus and mycophenolate mofetil on renal histology and function in single kidney rats submitted to ischemia and reperfusion.
Dias PH; Oliveira GA; Dias FG; Gomes Rde P; Tambara Filho R; Fraga Rd
Acta Cir Bras; 2015 Feb; 30(2):127-33. PubMed ID: 25714692
[TBL] [Abstract][Full Text] [Related]
62. Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trial.
Yoshida EM; Marotta PJ; Greig PD; Kneteman NM; Marleau D; Cantarovich M; Peltekian KM; Lilly LB; Scudamore CH; Bain VG; Wall WJ; Roy A; Balshaw RF; Barkun JS
Liver Transpl; 2005 Sep; 11(9):1064-72. PubMed ID: 16123958
[TBL] [Abstract][Full Text] [Related]
63. De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis.
Zucker MJ; Baran DA; Arroyo LH; Goldstein DJ; Neacy C; Mele L; Weinberg AD; Prendergast TW; Ribner HS
Transplant Proc; 2005 Jun; 37(5):2231-9. PubMed ID: 15964386
[TBL] [Abstract][Full Text] [Related]
64. What is the calcineurin inhibitor of choice for pediatric renal transplantation?
Kari JA; Trompeter RS
Pediatr Transplant; 2004 Oct; 8(5):437-44. PubMed ID: 15367278
[TBL] [Abstract][Full Text] [Related]
65. Quadruple immunosuppression with basiliximab, tacrolimus, mycophenolate mofetil and prednisone is safe and effective for renal transplantation.
Miura M; Harada H; Fukuzawa N; Iwami D; Taniguchi A; Seki T; Togashi M; Ogawa Y; Satoh H; Hirano T
Clin Transplant; 2005; 19 Suppl 14():54-8. PubMed ID: 15955170
[TBL] [Abstract][Full Text] [Related]
66. Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen.
Sampaio EL; Pinheiro-Machado PG; Garcia R; Felipe CR; Park SI; Casarini DE; Moreira S; Franco MF; Tedesco-Silva H; Medina-Pestana JO
Clin Transplant; 2008; 22(2):141-9. PubMed ID: 18339132
[TBL] [Abstract][Full Text] [Related]
67. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
Miller J; Mendez R; Pirsch JD; Jensik SC
Transplantation; 2000 Mar; 69(5):875-80. PubMed ID: 10755543
[TBL] [Abstract][Full Text] [Related]
68. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus.
Hunt SA
Cardiol Rev; 2000; 8(3):180-4. PubMed ID: 11174892
[TBL] [Abstract][Full Text] [Related]
69. Effectiveness and safety of immunosuppressive regimens used as maintenance therapy in kidney transplantation: The CESIT study.
Bellini A; Finocchietti M; Rosa AC; Nordio M; Ferroni E; Massari M; Spila Alegiani S; Masiero L; Bedeschi G; Cardillo M; Lucenteforte E; Piccolo G; Leoni O; Pierobon S; Ledda S; Garau D; Davoli M; Addis A; Belleudi V;
PLoS One; 2024; 19(1):e0295205. PubMed ID: 38165971
[TBL] [Abstract][Full Text] [Related]
70. Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil.
van Gelder T; ter Meulen CG; Hené R; Weimar W; Hoitsma A
Transplantation; 2003 Mar; 75(6):788-91. PubMed ID: 12660502
[TBL] [Abstract][Full Text] [Related]
71. Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus.
Dean PG; Lund WJ; Larson TS; Prieto M; Nyberg SL; Ishitani MB; Kremers WK; Stegall MD
Transplantation; 2004 May; 77(10):1555-61. PubMed ID: 15239621
[TBL] [Abstract][Full Text] [Related]
72. Improvement of drug-induced chronic renal failure in lung transplantation.
Soccal PM; Gasche Y; Favre H; Spiliopoulos A; Nicod LP
Transplantation; 1999 Jul; 68(1):164-5. PubMed ID: 10428288
[TBL] [Abstract][Full Text] [Related]
73. Treatment of pure red-cell aplasia with cyclosporine in a renal transplant patient.
Yildirim R; Bilen Y; Keles M; Uyanik A; Gokbulut P; Aydinli B
Exp Clin Transplant; 2013 Feb; 11(1):63-5. PubMed ID: 22891934
[TBL] [Abstract][Full Text] [Related]
74. The influence of exposure to immunosuppressive treatment during pregnancy on renal function and rate of apoptosis in native kidneys of female Wistar rats.
Kabat-Koperska J; Kolasa-Wołosiuk A; Baranowska-Bosiacka I; Safranow K; Kosik-Bogacka D; Gutowska I; Pilutin A; Gołembiewska E; Kędzierska K; Ciechanowski K
Apoptosis; 2016 Nov; 21(11):1240-1248. PubMed ID: 27586504
[TBL] [Abstract][Full Text] [Related]
75. [Mycophenolate mofetil, a possible new immunosuppresant].
Weberová J; Voboril R; Semecký V
Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
[TBL] [Abstract][Full Text] [Related]
76. Tolerance of enteric-coated mycophenolate sodium in combination with calcineurin inhibitor in kidney transplant recipients: Polish experience.
Gozdowska J; Urbanowicz AL; Galazka Z; Chmura A; Durlik M
Transplant Proc; 2011 Oct; 43(8):2946-9. PubMed ID: 21996197
[TBL] [Abstract][Full Text] [Related]
77. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.
Budde K; Glander P; Krämer BK; Fischer W; Hoffmann U; Bauer S; Grohmann J; Neumayer HH; Arns W
Transplantation; 2007 Feb; 83(4):417-24. PubMed ID: 17318074
[TBL] [Abstract][Full Text] [Related]
78. How cyclosporine reduces mycophenolic acid exposure by 40% while other calcineurin inhibitors do not.
van Gelder T
Kidney Int; 2021 Dec; 100(6):1185-1189. PubMed ID: 34284043
[TBL] [Abstract][Full Text] [Related]
79. Drug fever caused by mycophenolate mofetil in a renal transplant recipient--a case report.
Chueh SC; Hong JC; Huang CY; Lai MK
Transplant Proc; 2000 Nov; 32(7):1925-6. PubMed ID: 11120003
[No Abstract] [Full Text] [Related]
80. Chronic renal allograft rejection: no response to mycophenolate mofetil.
Glicklich D; Gupta B; Schurter-Frey G; Greenstein SM; Schechner RS; Tellis VA
Transplantation; 1998 Aug; 66(3):398-9. PubMed ID: 9721811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
